
CAS Number177036-94-1
SynonymsLetairis; (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid; (S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid; ambrisentan; (2S)-2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropanoic acid; UNII-HW6NV07QEC
Molecular FormulaC22H22N2O4
Molecular Weight378.42
Purity≥98 (HPLC)%
Density1.228g/cm3
Boiling Point551.1ºC at 760mmHg
Melting Point>150°C (dec.)
Appearancepowder
EINECS0
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 177036-94-1 |
| Catalog No. | 2A-2101096 |
| Chinese Name | 安倍生坦 |
| Synonyms | Letairis; (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid; (S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid; ambrisentan; (2S)-2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropanoic acid; UNII-HW6NV07QEC |
| Molecular Formula | C22H22N2O4 |
| Molecular Weight | 378.42 |
| Purity | ≥98 (HPLC) |
| Density | 1.228g/cm3 |
| Boiling Point | 551.1ºC at 760mmHg |
| Melting Point | >150°C (dec.) |
| Appearance | powder |
| Storage Condition | -20°C Freezer |
| Application | Ambrisentan is a selective ET type A receptor (ETAR) antagonist. |
| EINECS | 0 |
| HTC | 2933599090 |
| UN(IATA) | 0 |
| MDL Number | MFCD08672619 |
| SMILES | CC1=CC(C)=NC(O[C@@H](C(C2=CC=CC=C2)(OC)C3=CC=CC=C3)C(O)=O)=N1 |
| InChI | 1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26) |
| InChI Key | OUJTZYPIHDYQMC-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 41121706 |
| MSDS | msds/101096_1_177036_94_1.pdf |
| Use of | Ambrisentan is a selective ET type A receptor (ETAR) antagonist. Properties Name (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid Synonym More Synonyms Ambrisentan Biological Activity Description Ambrisentan is a selective ET type A receptor (ETAR) antagonist. Related Catalog Signaling Pathways >> GPCR/G Protein >> Endothelin Receptor Research Areas >> Cardiovascular Disease ETA receptor[1] In Vitro Ambrisentan is an endothelin type A receptor antagonist[1]. Ambrisentan induces Nrf2 activation. Endothelial permeability increased in BMEC monolayers at 24 h of hypoxia exposure and compared to vehicle control, Ambrisentan attenuates hypoxia-induced BMEC leak. These results are reversed when prior to treatment BMEC are transfected with siRNA against Nrf2[2]. References [1]. Okamoto T, et al. Antifibrotic effects of Ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model. World J Hepatol. 2016 Aug 8;8(22):933-41. [2]. Lisk C, et al. Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. Free Radic Biol Med. 2013 Oct;63:264-73. Chemical & Physical Properties Molecular Formula C22H22N2O4 Exact Mass 378.15800 PSA 81.54000 LogP 3.51560 Index of Refraction 1.593 InChIKey OUJTZYPIHDYQMC-LJQANCHMSA-N Safety Information RTECS UA2459660 HS Code 2933599090 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-2-(2-BROMOPHENYL)-4-(TERT-BUTYL)-4,5-DIHYDROOXAZOLE | 154701-60-7 | 2A-0101082 |
| (S)-2-(2-CHLORONICOTINAMIDO)-4-(METHYLTHIO)BUTANOIC ACID | 175201-49-7 | 2A-0101083 |
| (S)-2-(3,4-DIMETHYLPHENYL)PIPERIDINE | 1213162-87-8 | 2A-0101089 |
| (S)-2-(3,5-DIMETHYLPHENYL)PYRROLIDINE HYDROCHLORIDE | 1245649-28-8 | 2A-0101091 |
| (S)-2-(3-BROMOPROPYL)-1,1-DIMETHYLCYCLOPROPANE | 130995-39-0 | 2A-0101094 |
| (S)-2-(4-((TERT-BUTOXYCARBONYL)AMINO)-2-OXOPYRROLIDIN-1-YL)ACETIC ACID | 135415-24-6 | 2A-0101098 |
| (S)-2-(4-(2-((2-HYDROXY-3-PHENOXYPROPYL)AMINO)ETHOXY)PHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE HYDROCHLORIDE | 129689-30-1 | 2A-0101099 |
| (S)-2-(4-CHLOROPHENYL)-2-HYDROXYACETIC ACID | 76496-63-4 | 2A-0101102 |
| (S)-2-(4-CHLOROPHENYL)OXIRANE | 97466-49-4 | 2A-0101104 |
| (S)-2-(4-NITROBENZAMIDO)PENTANEDIOIC ACID | 6758-40-3 | 2A-0101106 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA